Financial report interval: 2024.12.31 - 2025.12.31
Overview: DUALITYBIO-B(09606) the Revenue is 2.059 B (--%), Beat estimate;the EBIT is -541.41 M (--%), Miss estimate;the EPS is -44.26 (+68.31%), Miss estimate.